Kolexia
Marchandot Benjamin
Cardiologie
Hôpital Civil
Strasbourg, France
170 Activités
1 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Hémorragie Thrombose Sténose aortique Choc Choc cardiogénique Défaillance cardiaque Syndrome coronarien aigu Syndrome de tako-tsubo

Industries

Servier
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
2 collaboration(s)
Dernière en 2020
Janssen
1 collaboration(s)
Dernière en 2023

Dernières activités

Association between prosthesis-patient mismatch and valve thrombosis: an independent link?
The Canadian journal of cardiology   02 mars 2024
Fostering Cardio-Endometriosis: A Call to Action for a Comprehensive Understanding of Cardiovascular Disease in Endometriosis.
European journal of preventive cardiology   29 février 2024
Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
Journal of the American Heart Association   23 février 2024
2024: Year one-from inception to mass disruption of artificial intelligence in cardiology.
European heart journal open   17 janvier 2024
Extensive Impairment of the Hemostatic System Increases Bleeding Events: The Potential of CT-ADP.
JACC. Cardiovascular interventions   16 décembre 2023
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
International journal of cardiology   11 novembre 2023
Human calcified aortic valves release procoagulant microparticles inducing endothelial dysfunction and thrombogenicity: Role of the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
ESC Congress 2023 25–28 August 2023 Amsterdam, Netherlands Abstract Supplement   09 novembre 2023
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
ESC Congress 2023 25–28 August 2023 Amsterdam, Netherlands Abstract Supplement   09 novembre 2023
Characteristics, management, and outcomes of active cancer patients with cardiogenic shock.
European heart journal. Acute cardiovascular care   27 octobre 2023
Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?
European heart journal   16 octobre 2023